University of Leeds Featured PhD Programmes
King’s College London Featured PhD Programmes
Catalysis Hub Featured PhD Programmes
Newcastle University Featured PhD Programmes
University of Bristol Featured PhD Programmes
"drug" AND "resistance"×
10 miles

drug resistance PhD Projects, Programs & Scholarships

We have 45 drug resistance PhD Projects, Programs & Scholarships

  • "drug" AND "resistance" ×
  • clear all
Order by 
Showing 1 to 10 of 45
  Overcoming drug resistance in cancer using nano-encapsulated combination therapies
  Dr M Jones
Applications accepted all year round
Despite advances in cancer treatment, the development of drug resistance remains a major issue affecting long term patient survival.
  Understanding the role of the globin cytoglobin in cancer cell drug resistance
  Dr N J Hodges
Applications accepted all year round
Cytoglobin is related to haemoglobin and myoglobin but has a very poorly understood biological function. Work in our lab has shown that expression of cytoglobin in cancer cells alters mitochondrial function and affords protection from anti-cancer drugs including cisplatin.
  Understanding drug-resistance in myeloid cancer
  Dr P Laslo
Applications accepted all year round
Under pathogenic challenges, cells of the innate system become epigenetically reprogrammed and establish immune memory.
  The role of tumour microenvironment interactions in melanoma therapy resistance
  Research Group: Institute of Cancer Therapeutics
  Dr H Sheldrake, Dr M Sutherland
Applications accepted all year round
The incidence of malignant melanoma has steadily increased over the past 30 years, and it is predicted that 76,250 new cases will be diagnosed in the US and over 10,000 in the UK this year.
  Dynamic changes in FANC protein expression in ovarian cancer– impact on chemosensitivity and resistance
  Research Group: Edinburgh Cancer Research Centre
  Dr S Langdon, Prof M Arends
Application Deadline: 21 April 2019
This 3-year PhD studentship funded by the Melville Trust is available to start in September 2019 at the Cancer Research UK Edinburgh Centre, which is part of the Institute of Genetics and Molecular Medicine (IGMM) at the University of Edinburgh.
  Development of stimuli-responsive metallosupramolecular architectures for sensing and/or delivery of medicine for the treatment of solid tumours
  Research Group: Chemistry and Biosciences
  Dr D Petty, Dr M Najafzadeh, Dr S Pike
Applications accepted all year round
Applications are invited for a new self-funded PhD opportunity in the School of Chemistry & Biosciences at the University of Bradford.
  Exploration of 5-fluorouracil resistance mechanisms in colorectal cancer using 5-FU-resistant xenograft models
  Research Group: Institute of Cancer Therapeutics
  Dr S Shnyder, Dr C Sutton
Applications accepted all year round
Despite therapeutic advances, colorectal cancer (CRC) still has a 45% mortality rate, and one of the major problems is the development of acquired resistance to treatment with anticancer drugs.
  Nanotechnologies for cancer: developing new polymer-drug conjugates for the treatment of a range of cancers
  Dr F Greco, Prof H Osborn
Applications accepted all year round
Polymer anticancer-drug conjugates are drug delivery systems in which a low molecular weight anticancer agent is covalently conjugated to a water-soluble polymeric carrier.
  Tumour microenvironment and colorectal cancer development: understanding the mechanisms of the tumour growth
  Prof D Kerr, Dr S Cai
Application Deadline: 26 July 2019
Our group has conducted a series of international adjuvant trials of chemotherapy for colorectal cancer (Kerr RS. et al, (2016), Lancet Oncol, 17, 1543 – 1557).
Show 10 15 30 per page


FindAPhD. Copyright 2005-2019
All rights reserved.